Your browser doesn't support javascript.
loading
FOXP3+/CD68+ ratio within the tumor microenvironment may serve as a potential prognostic factor in classical Hodgkin lymphoma.
Zawati, Imen; Adouni, Olfa; Manai, Maroua; Nagara, Majdi; Tacam, Moisis; Reduzzi, Carolina; Gamoudi, Amor; Manai, Mohamed.
Afiliação
  • Zawati I; Department of Immuno-Histo-Cytology, Salah Azaiez Institute, 1006 Tunis, Tunisia; Department of Biology, Mycology, Pathologies, and Biomarkers Laboratory (LR16ES05), Faculty of Sciences of Tunis, University of Tunis El Manar, 2092 Ariana, Tunisia. Electronic address: zawati.imen88@gmail.com.
  • Adouni O; Department of Immuno-Histo-Cytology, Salah Azaiez Institute, 1006 Tunis, Tunisia; Department of Biology, Mycology, Pathologies, and Biomarkers Laboratory (LR16ES05), Faculty of Sciences of Tunis, University of Tunis El Manar, 2092 Ariana, Tunisia.
  • Manai M; Department of Immuno-Histo-Cytology, Salah Azaiez Institute, 1006 Tunis, Tunisia; Laboratory of Human Genetics (LR99ES10), Faculty of Medicine of Tunis, University of Tunis El Manar, 2092 Tunis, Tunisia; Department of Medicine, Division of Hematology-Oncology, Weill Cornell Medicine, 1300 York Ave,
  • Nagara M; Inserm, UMR-S 1251, MMG, Faculty of Medicine Timone, Aix Marseille University, Marseille, France.
  • Tacam M; Department of OB/Gyn, Baylor College of Medicine, Texas Children's Hospital, Houston, TX, USA.
  • Reduzzi C; Department of Medicine, Division of Hematology-Oncology, Weill Cornell Medicine, 1300 York Ave, 10021 NY, NY, USA.
  • Gamoudi A; Department of Immuno-Histo-Cytology, Salah Azaiez Institute, 1006 Tunis, Tunisia.
  • Manai M; Department of Biology, Mycology, Pathologies, and Biomarkers Laboratory (LR16ES05), Faculty of Sciences of Tunis, University of Tunis El Manar, 2092 Ariana, Tunisia.
Hum Immunol ; 83(12): 843-856, 2022 Dec.
Article em En | MEDLINE | ID: mdl-36068099

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Doença de Hodgkin Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Hum Immunol Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Doença de Hodgkin Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Hum Immunol Ano de publicação: 2022 Tipo de documento: Article